Member Info for LuckyLuciano

Faz41
from my understanding the more accurate is a test that counts IgG and IgM not just IgG (immunoglobulin G)
there are also other test that claim to do total antibody test which i suppose do count all the immunoglobulin.
The thing is been a new virus nobody can say for sure the accuracy of any test, this can be valid also for old in use tests carried out by many hospitals and for many disease . But I suppose for this virus been so much under the microscope with so much media attention and been so deadly, nobody like to take the responsibility to claim that one test is the for sure best test of all. then again if I was to but a test I would prefer the most complete ans precise test on the market...

Scusa Scuadrazzurra BUT how is flyingmachine the CEO of Omega?

Anyway I would have thought that is Mologic production facility was a collaboration with Omega it would have been posted as RNS by Omega too.
Beside thanks flyingmachine you answer my question The Mologic/Omega test is only lgG antibody count (if remember correct is the detection of the "spike protein" trace of the virus).
Thanks

Many thanks maqsood7
have bookmarked link very useful but I could't see any mentioning of Omega/Mologic test.
Also an eye opening to realise how many companies are producing these test kits. I was trying to look for a company that produce a reliable test-kit if actually there is one....Apparently some test-kit detect only if the infection as occurred before a certain number of days, other are able to detect if one has been infected from a longer time frame...
I am already invested in a US company that is undergoing validation but is already FDA Emergency approved and CE Marked and is already selling the kit, I was looking for something similar in the UK market but it looks like I may got here a bit too late. Anyway thanks

Hi please does anyone know how accurate is the text-kit of Omega/Mologic?
As far I understand Omega is working on 2 test in parallel, one with the consortium and UK gov. the other with the help of Mologic know-how , this last test-kit been already tested and CE approved .
I was reading that Mologic are going ahead with their own manufacturing of the Covi test-kit 40 milion per year from june theoretically becoming competitors of Omega...
Anyway what I am looking for is to know the accuracy of this test, is it a serology test with Total antibody count, with only lgG, or with lgG and lgM??

It you like to stick to uk shares don't forget SYNG

Scart what I mean is that GRD before making the 8/10£ per test, a client (if I understand it correct) has to buy the machine.
Considering that there are already lots of platforms for testing covi out there i honestly can't see this huge commercial potential for this product...but I am probably wrong.

Beside timing of rns or price of placing, now investors here are awaiting sales to start to materialise.
Have to say if you are on a good profit on this share and still holding, I take my hat of for you. Then again I read post here from people talking about the "big picture" and that these machines save lives and all that.....then I wonder if that is the case, wouldn't be better to donate or do some charity to hospital than invest in AIM companies?
Lest be hones here we are all here to make money, some did some are stuck with this because bought at £3 some other beside the profit are hoping to see a higher sp in the future coming from sales materialising. Just be aware this company doesn't produce test kit that are going to be sold in their millions, if I read correctly they produce machines that analyse those COVI 19 test kit, therefore once a hospital or whoever want it buy one of theses machine that is it, so the market is limited and also there are already other similar machine out there already selling into the market. So back to where we are now with the sp, I suppose this share has become a fundamental investor share not a news driven share.

Let's not forget the hundreds of millions of pounds profit they'll make over the next two years
========================================================================
lol now this guy know something!!!! lololo Have to give it to you mate. You shoUld ask to work for Genedrive, they would make you CEO.

Mr Speculator I 1000% with you.
The timing is shameless, is there any one so kind to explain the reason why the BoD chose this timing ?

I am sorry bigbench but do you have some inside information regarding how the sp of 80p was arranged?
The rns about share placing is not transparent, normally they would specify which period is taken in consideration to decide the sp average, I cant see it in black on white from the rns can you?
Moreover maybe I missed it but, do you have details of the agreement with Cytiva to produce the test kit?
(genuine question)
Anyway I take you point obviously no institutional investor would have subscribe shares at £3
My feeling is that they should have handled this fund rise much better, I am not sure if they ever applied for grant from any CEPI or BARDA or else. Looks like they rushed this project with a bit too much enthusiasm but if their Diagnostic kit is so transformation why not take the time to capitalise on it......wait I forgot Bosch and other company are producing it already.

..previews week on a weekly bar chart is opening at 84 and closing at 135

..May be bigbench but i wouldn't risk my money in a company that sell its shares at 80p to institutional investors when the sp is above 2£. What argument have you got beside calling people names....?

This is going to tumble go down and down.....
They sold the company at 80p to institutions, no chance for retail shareholders like you to buy at 80p. take profit till you can. If you are losing you can only hope that in mid/long terms the sale will start to materialise and that they are going to be enough to support the share price.

What about Applied DNA (nasdaq)In the process to validate their test kit, for then apply to the US/FDA
But also more importantly doing a pre-clinical trial for CoVi19 vaccine.
Market cap 24 mil $.

In my opinion CCL will never go to the wall, there always be money around to finance this kind of cash generating company and beside CCL is the biggest in the world. If some oilier manage to survive at today oil price, by keeping renegotiating their debit to infinity, why shouldn't CCL. Cruise Liner as no rival it will always exist, is not like high street retails that can be replaced by internet shopping. About the current situation and CoVi19 sure, we can all debate about which entry price is a bargain a gamble or long term investment, but what's the point.

On another note I just hope that whatever is the outcome of the court hearing, PMO BoD will scrap the latest acquisition.
For start there must be lots of free money floating around right now, so at least a renegotiation of credit arrangement , and not just for this acquisition is a must. Secondly if they keep piling on debit, when are they ever going to pay dividends (unless they thing one day oil price will reach $200 a barrel). I think PMO share price will surely see better days, with oil price at these levels not just Russia is going to suffer, rumours of a Saudi US cut deal may well be true. One thing is for sure oil price at this level will have a final and devastating effect on the environment.

Just herd that Boing is going to get billions $ help from US government. This is the land of the free, lol, promising billions to the people that right now are spending money from their pocket to survive.....but NO! With this imminent danger, why don't we bail out a company that is making air-plains. Some people have no shame .

Manraj....me too.
unbelievable had a order at best with indicative price below 10p for 20 minutes without been executed at any price. Had to call to cancel it because now they are making it even more difficult for us to cancel trade, for them to do whatever they like with our money.

Thanks for your reply MikeyT
but still to me there is too much difference in revenue between Genl/Gkp.
I suppose the question I am asking is if anyone know what is the GKP share of production....because according to my calculation actually it appear that GKP sell oil at 44.8$ pb wheres Genl sell it at 28.8$ ~(and because of the oil quality it should be the opposite, maybe not with this ratio) ..one more reason to try to understand this matter.

............another reason for the incongruity in reporting revenue and production, by gkp and genl, could be the fact that Gkp reports non IFRS accounting info, wheres Genl adhere to IFRS reporting standards ?!